B. Schnyder et al., DISTRIBUTION PATTERN OF TENASCIN-C IN NORMAL AND NEOPLASTIC MESENCHYMAL TISSUES, International journal of cancer, 72(2), 1997, pp. 217-224
Descriptions for tenascin-C distribution are largely restricted to epi
thelial tumours, The present study utilized newly developed and charac
terized monoclonal (hT191) and polyclonal antibodies to investigate th
e distribution pattern of tenascin-C in a panel of mesenchymal tumours
, which was contrasted with normal tissue. The specific antibodies rec
ognized the distinctive star-like hexabrachion protein isolated from t
ransformed cell-culture medium and serum from normal individuals, In n
ormal tissues, a strong tenascin-C expression in the extracellular mat
rix was largely restricted to basement-membrane regions of epithelium
and tonsilar sinusoids, pericellularly within smooth-muscle bundles, a
ssociated with perimysial, -chondrial, -neurial and -tendon surfaces,
and diffusely within vascular adventitia, it was found in the correspo
nding tumours of the neural sheath (schwannoma) and smooth muscle (lei
omyosarcoma), and was abundantly present around certain blood vessels
of mesenchymal tumours. Although not detected in normal muscle, or in
adipose or fibrous connective tissue, neo-expression of tenascin-C was
shown in more than half of the rhabdomyosarcomas, fibromas and liposa
rcomas, with an increased positive percentage in variably malignant my
xoid liposarcomas compared with lipoma-like sarcomas, Tenascin-C was t
ypically found in the extracellular matrix of soft-tissue tumours, but
was notably absent from the epithelial-cell components of mixed epith
elial/mesenchymal tumours, Its apparently enhanced expression in soft-
tissue tumours differs from that of most other large extracellular-mat
rix proteins, suggesting possible functional involvement of the cell-a
dhesion molecule, tenascin-C, in the neoplastic phenotype. (C) 1997 Wi
ley-Liss, Inc.